FDA Approves Pfizer/BioNTech COVID-19 Vaccine
Coronavirus (COVID-19) Update: December 10, 2020 https://t.co/TYDuFAINCy— Carol Duff (@CarolDuff18) December 11, 2020
Health Editor’s Note: Based on all scientific evidence that is available the FDA advisory committee voted to recommend Pfizer/BioNTech mRNA COVID-19 vaccine candidate for use in people age 16 and older in an emergency use authorization capacity.
The efficacy for this vaccine is 95% seven days after the second vaccine dose. Reactions to the vaccine are injection site reactions, fatigue, and headache with were more common in people younger than 55. The vaccine should not be administered to anyone who has had a severe allergic reaction to components of this vaccine.
On December 17, there will another discussion for another EUA for a COVID-19 vaccine, this time for Moderna’s mRNA COVID-19 vaccine…..Carol